|Articles|June 21, 2023
Mass Spectrometry Imaging: Top 8 benefits in oncology drug discovery and development
Author(s) Pyxant
Mass spectrometry imaging (MSI) is beneficial in early development and murine models across many therapeutic areas. This technique is especially suited for oncology due to the availability of tissue.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
US Withdrawal From WHO Creates New Pharma Logistics Vulnerabilities
2
Securing Radiopharma and GLP-1 Supply Chains Through 2026 M&A
3
Halo Pharma Becomes Dedicated North American Drug Product CDMO
4
Lilly Invests $3.5B in Pennsylvania Injectable Medicine Facility
5